Home » Generics » Dossier


Olon is expanding its business in the generic market also through Finish Dosage Forms (FDFs), taking advantage of its strong position in API development and manufacturing.
As part of our service to our customers, we offer opportunities for both in-licensing available products and partnerships for generic products development.
If you are looking for a smart approach, cost effectiveness and flexibility, Olon is the right partner, back integrated on APIs thanks to our 11 plants across 3 difference continents, and ready to provide FDF by its broad and reliable network of CDMOs.

In this process, you will not be just a customer, but a partner fully involved in the project definition and decisions, through constant, proactive and transparent communication, as we are both engaged to achieve the same result: successfully complete the FDF development, dossier registration and commercialization.